Literature DB >> 22807295

Exclusion of RPGRIP1 ins44 from primary causal association with early-onset cone-rod dystrophy in dogs.

Tatyana Kuznetsova1, Simone Iwabe, Kathleen Boesze-Battaglia, Sue Pearce-Kelling, Yim Chang-Min, Kendra McDaid, Keiko Miyadera, Andras Komaromy, Gustavo D Aguirre.   

Abstract

PURPOSE: Canine cone-rod dystrophy 1 (cord1) has been previously mapped to CFA15, and a homozygous 44-bp insertion in exon 2 (Ins44) of canine RPGRIP1 (cRPGRIP1(Ins/Ins)) has been associated with the disease. However, from the recent identification of a significant discordance in genotype-phenotype association, we have reexamined the role of cRPGRIP1 in cord1.
METHODS: Retinal structure and function was assessed by clinical retinal examination, noninvasive imaging, electroretinography, and histopathology/immunohistochemistry. cRPGRIP1 splicing was analyzed by RT-PCR. Retinal gene expression was determined by quantitative RT-PCR (qRT-PCR). Five markers spanning the entire cRPGRIP1 were identified and used for haplotyping.
RESULTS: Electroretinography demonstrated that cone responses were absent or present in cRPGRIP1(Ins/Ins) individuals. Moreover, performance in vision testing and optical coherence tomography (OCT) were comparable in cRPGRIP1(Ins/Ins) dogs, regardless of the cone ERG status. While histologic changes in retinal structure were minimal, immunohistochemistry demonstrated a lack of cone opsin labeling in cRPGRIP1(Ins/Ins) dogs. cDNA analysis revealed that Ins44 disrupts a putative exonic splicing enhancer that allows for skipping of exon 2, while retaining the functional RPGR-interacting domain (RID) of the protein. New cRPGRIP1 sequence changes were identified, including a 3-bp deletion affecting the 3' acceptor splice site of alternative exon 19c. The extended haplotype spanning cRPGRIP1 was identical in cRPGRIP1(Ins/Ins) dogs with and without retinal degeneration. Gene expression analysis showed that expression levels were not associated with Ins44 genotype.
CONCLUSIONS: The results indicated that cRPGRIP1 Ins44 is an unlikely primary cause of cord1, and that the causal gene and mutation are likely located elsewhere in the critical disease interval.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807295      PMCID: PMC3422103          DOI: 10.1167/iovs.12-10178

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  Limited proteolysis differentially modulates the stability and subcellular localization of domains of RPGRIP1 that are distinctly affected by mutations in Leber's congenital amaurosis.

Authors:  Xinrong Lu; Mallikarjuna Guruju; John Oswald; Paulo A Ferreira
Journal:  Hum Mol Genet       Date:  2005-03-30       Impact factor: 6.150

Review 2.  Alternative splicing: new insights from global analyses.

Authors:  Benjamin J Blencowe
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

3.  In vitro polyadenylation is stimulated by the presence of an upstream intron.

Authors:  M Niwa; S D Rose; S M Berget
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

Review 4.  Protein networks and complexes in photoreceptor cilia.

Authors:  Ronald Roepman; Uwe Wolfrum
Journal:  Subcell Biochem       Date:  2007

5.  Canine RPGRIP1 mutation establishes cone-rod dystrophy in miniature longhaired dachshunds as a homologue of human Leber congenital amaurosis.

Authors:  C S Mellersh; M E G Boursnell; L Pettitt; E J Ryder; N G Holmes; D Grafham; O P Forman; J Sampson; K C Barnett; S Blanton; M M Binns; M Vaudin
Journal:  Genomics       Date:  2006-06-27       Impact factor: 5.736

6.  A frameshift mutation in RPGR exon ORF15 causes photoreceptor degeneration and inner retina remodeling in a model of X-linked retinitis pigmentosa.

Authors:  William A Beltran; Pamela Hammond; Gregory M Acland; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

7.  A deletion in nephronophthisis 4 (NPHP4) is associated with recessive cone-rod dystrophy in standard wire-haired dachshund.

Authors:  Anne Caroline Wiik; Claire Wade; Tara Biagi; Ernst-Otto Ropstad; Ellen Bjerkås; Kerstin Lindblad-Toh; Frode Lingaas
Journal:  Genome Res       Date:  2008-08-07       Impact factor: 9.043

8.  Pathological and electrophysiological features of a canine cone-rod dystrophy in the miniature longhaired dachshund.

Authors:  Clare Turney; N H Victor Chong; Robert A Alexander; Chris R Hogg; Lorraine Fleming; Deborah Flack; Keith C Barnett; Alan C Bird; Graham E Holder; Philip J Luthert
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

Review 9.  Splicing in disease: disruption of the splicing code and the decoding machinery.

Authors:  Guey-Shin Wang; Thomas A Cooper
Journal:  Nat Rev Genet       Date:  2007-08-29       Impact factor: 53.242

10.  Analysis of six candidate genes as potential modifiers of disease expression in canine XLPRA1, a model for human X-linked retinitis pigmentosa 3.

Authors:  Richard Guyon; Susan E Pearce-Kelling; Caroline J Zeiss; Gregory M Acland; Gustavo D Aguirre
Journal:  Mol Vis       Date:  2007-07-11       Impact factor: 2.367

View more
  12 in total

1.  A novel exon 17 deletion mutation of RPGRIP1 gene in two siblings with Leber congenital amaurosis.

Authors:  Takahide Suzuki; Takuro Fujimaki; Ai Yanagawa; Eisuke Arai; Keiko Fujiki; Yuko Wada; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2014-08-07       Impact factor: 2.447

2.  Canine genome assembly correction facilitates identification of a MAP9 deletion as a potential age of onset modifier for RPGRIP1-associated canine retinal degeneration.

Authors:  Oliver P Forman; Rebekkah J Hitti; Mike Boursnell; Keiko Miyadera; David Sargan; Cathryn Mellersh
Journal:  Mamm Genome       Date:  2016-03-26       Impact factor: 2.957

Review 3.  Leber congenital amaurosis caused by mutations in RPGRIP1.

Authors:  Tiansen Li
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-20       Impact factor: 6.915

Review 4.  Dog models for blinding inherited retinal dystrophies.

Authors:  Simon M Petersen-Jones; András M Komáromy
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-11       Impact factor: 5.032

5.  Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy.

Authors:  Elsa Lhériteau; Lolita Petit; Michel Weber; Guylène Le Meur; Jack-Yves Deschamps; Lyse Libeau; Alexandra Mendes-Madeira; Caroline Guihal; Achille François; Richard Guyon; Nathalie Provost; Françoise Lemoine; Samantha Papal; Aziz El-Amraoui; Marie-Anne Colle; Philippe Moullier; Fabienne Rolling
Journal:  Mol Ther       Date:  2013-10-04       Impact factor: 11.454

6.  Investigating the inheritance of prolapsed nictitating membrane glands in a large canine pedigree.

Authors:  Michele L Edelmann; Keiko Miyadera; Simone Iwabe; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2012-12-13       Impact factor: 1.644

Review 7.  The genetics of inherited retinal disorders in dogs: implications for diagnosis and management.

Authors:  Anna Palanova
Journal:  Vet Med (Auckl)       Date:  2016-03-15

8.  A Naturally Occurring Canine Model of Autosomal Recessive Congenital Stationary Night Blindness.

Authors:  Mineo Kondo; Gautami Das; Ryoetsu Imai; Evelyn Santana; Tomio Nakashita; Miho Imawaka; Kosuke Ueda; Hirohiko Ohtsuka; Kazuhiko Sakai; Takehiro Aihara; Kumiko Kato; Masahiko Sugimoto; Shinji Ueno; Yuji Nishizawa; Gustavo D Aguirre; Keiko Miyadera
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  Variabilities in retinal function and structure in a canine model of cone-rod dystrophy associated with RPGRIP1 support multigenic etiology.

Authors:  Rueben G Das; Felipe Pompeo Marinho; Simone Iwabe; Evelyn Santana; Kendra Sierra McDaid; Gustavo D Aguirre; Keiko Miyadera
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

Review 10.  Large Animal Models of Inherited Retinal Degenerations: A Review.

Authors:  Paige A Winkler; Laurence M Occelli; Simon M Petersen-Jones
Journal:  Cells       Date:  2020-04-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.